Taysha Gene Therapies, Inc. - COM SHS (TSHA)

Q1 2024 Portfolio Holders as of 3/31/2024

Type / Class
Equity / COM SHS
Number of holders
106
Total Shares
140M
Shares change
+10M
Total reported value, excl. options
$402M
Value change
+$33.4M
Put/Call ratio
1.47
Number of buys
62
Number of sells
-41
Price
$2.87
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.